- Adults (18-64 years)
- General population
- Hospital
- Outpatient clinic
- SARS-CoV-2
- Pharmacological intervention
- Vaccination
Setting: Hospital
Encompassing all units and departments within a hospital setting
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Outpatient clinic
- SARS-CoV-2
- Pharmacological intervention
- Vaccination
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Outpatient clinic
- SARS-CoV-2
- Pharmacological intervention
- Vaccination
- Infants (<1 year)
- Fragile population
- Hospital
- Outpatient clinic
- SARS-CoV-2
- Pharmacological intervention
- Vaccination
- Adults (18-64 years)
- General population
- Hospital
- Outpatient clinic
- SARS-CoV-2
- Non pharmacological intervention
- Essential Oils
- Adults (18-64 years)
- Elderly (≥65 years)
- Immunocompromised patients
- Hospital
- SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Remdesivir
- Ibuzatrelvir
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Outpatient clinic
- SARS-CoV-2
- Respiratory syncytial virus
- Influenza virus
- Influenza A
- Influenza B
- Pharmacological intervention
- Immunomodulator
- PRS CK STORM
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Monoclonal antibodies
- Remdesivir
- Tixagevimab/Cilgavimab
- Hydroxychloroquine
- Interferon Beta-1A
- Lopinavir/ritonavir
- Adults (18-64 years)
- Elderly (≥65 years)
- Immunocompromised patients
- Hospital
- SARS-CoV-2
- Respiratory syncytial virus
- Influenza virus
- Adenovirus
- Rhinovirus
- Human metapneumovirus
- Parainfluenza Virus
- Pharmacological intervention
- Antivirals
- SNG001
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Outpatient clinic
- SARS-CoV-2
- Pharmacological intervention
- Vaccination
- Nasal vaccine
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Apo-Si-K170A-C76
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- SARS-CoV-2
- Non pharmacological intervention
- Rehabilitation
- Education